DJIA 18,034.93 208.63 1.17%
NASDAQ 4,994.60 62.79 1.27%
S&P 500 2,100.40 19.22 0.92%
market minute promo

Oncothyreon, Inc. (NASDAQ: ONTY)

1.75 0.03 (1.74%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ONTY $1.75 1.74%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.73
Previous Close $1.72
Daily Range $1.71 - $1.76
52-Week Range $1.48 - $3.60
Market Cap $179.0M
P/E Ratio -2.69
Dividend (Yield) $0.00 (0.0%)
Volume 455,645
Average Daily Volume 823,526
Current FY EPS -$0.34

Sector

Healthcare

Industry

Drug Makers

Oncothyreon, Inc. (ONTY) Description

Oncothyreon Inc. is a clinical-stage biopharmaceutical company which is focused on the development of therapeutic products for the treatment of cancer. Website: http://www.oncothyreon.com/

News & Commentary Rss Feed

Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma Inc. Stocks Jumped Today

Three biotechs climb after a competitor's trial success boosts hope across the HER-2 breast cancer treatment market

Celldex Therapeutics Pushes Forward With Varlilumab And Further Proves Its Worth

Oncothyreon (ONTY) Shares March Higher, Can It Continue? - Tale of the Tape

Oncothyreon (ONTY) Shares March Higher, Can It Continue? - Tale of the Tape

Oncothyreon Inc. (ONTY) in Focus: Stock Rises 6.3% - Tale of the Tape

Oncothyreon Inc. (ONTY) in Focus: Stock Rises 6.3% - Tale of the Tape

Benzinga's Top Initiations

Oncothyreon (ONTY) CEO Dr. Robert Kirkman on Q4 2014 Results - Earnings Call Transcript

UPDATE: Oncothyreon Shares Drop After Q4 Results

Oncothyreon Inc . (ONTY) Q4 2014 Results - Earnings Call Webcast

Should You Buy Oncothyreon Inc (ONTY) Ahead of Earnings? - Tale of the Tape

Weekly Analyst Highlights: Oil, Tesla On Readers' Minds

How Wall Street Is Reacting To The Pharmacyclics Rumor

See More ONTY News...

ONTY's Top Competitors

ONTY $1.75 (1.74%)
Current stock: ONTY
AMGN $165.97 (1.46%)
Current stock: AMGN
GILD $100.66 (-0.72%)
Current stock: GILD
BIIB $422.92 (0.83%)
Current stock: BIIB